Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will present its latest advances in soft-tissue reconstruction at Piper Sandler’s 37th Annual Healthcare Conference, the company announced, marking another opportunity for …
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced a new round of equity awards designed to attract and retain talent as the commercial-stage medtech firm expands its workforce and …
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported continued revenue growth and operational progress in the third quarter of 2025, supported by a strengthened leadership team, expanded sales infrastructure, …
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced it will release its third-quarter 2025 financial results on Thursday, November 13, 2025, followed by a conference call and webcast at …
TELA Bio to Announce Q3 2025 Results, Host Investor Call November 13 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of William “Bill” Plovanic, CFA, to its Board of Directors, bringing more than 25 years of experience in capital …
TELA Bio Adds Veteran MedTech Executive Bill Plovanic to Board of Directors Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of Betty Jo Rocchio, DNP, RN, CRNA, CENP, EBP-C, to its Board of Directors, succeeding Lisa Colleran, who stepped …
TELA Bio Appoints Healthcare Leader Betty Jo Rocchio to Board of Directors Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) reported a strong second quarter for 2025, delivering $20.2 million in revenue, up 26% from the same period last year and 9% …
TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has granted restricted stock units (RSUs) covering 10,200 shares of its common stock to fourteen newly hired employees as part of their …
TELA Bio Awards Inducement Equity Grants to New Employees Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced its participation in the Canaccord Genuity 45th Annual Growth Conference.
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced that its Board of Directors Compensation Committee approved an inducement grant for Jim Hagen, Senior Vice President – Strategic Commercial Operations. …
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant Read More